THE NKG2D SYSTEM MEDIATES ANTI-TUMOR EFFECTS OF CHEMOTHERAPY AND RADIOTHERAPY AGAINST GLIOBLASTOMA

被引:0
作者
Weiss, T. [1 ,2 ,3 ]
Schneider, H. [1 ,2 ,3 ]
Silginer, M. [1 ,2 ,3 ]
Steinle, A. [4 ]
Pruschy, M. [3 ,5 ]
Weller, M. [1 ,2 ,3 ]
Roth, P. [1 ,2 ,3 ]
机构
[1] Univ Hosp, Dept Neurol, Zurich, Switzerland
[2] Univ Hosp, Brain Tumor Ctr, Zurich, Switzerland
[3] Univ Zurich, Zurich, Switzerland
[4] Goethe Univ Frankfurt, Inst Mol Med, Frankfurt, Germany
[5] Univ Hosp, Dept Radiat Oncol, Zurich, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P08.22
引用
收藏
页码:45 / 45
页数:1
相关论文
共 50 条
  • [31] Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D
    Wang, Zhongjuan
    Guo, Linghua
    Song, Yuan
    Zhang, Yinsheng
    Lin, Dandan
    Hu, Bo
    Mei, Yu
    Sandikin, Dedy
    Liu, Haiyan
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (04) : 537 - 548
  • [32] NK Cell Anti-Tumor Reactivity Is Impaired by Platelet-Derived TGF-B through NKG2D Downregulation.
    Kopp, Hans-Georg
    Placke, Theresa
    Schmiedel, Benjamin J.
    Kanz, Lothar
    Krusch, Matthias
    Salih, Helmut R.
    BLOOD, 2008, 112 (11) : 986 - 987
  • [33] Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D
    Zhongjuan Wang
    Linghua Guo
    Yuan Song
    Yinsheng Zhang
    Dandan Lin
    Bo Hu
    Yu Mei
    Dedy Sandikin
    Haiyan Liu
    Cancer Immunology, Immunotherapy, 2017, 66 : 537 - 548
  • [34] Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects
    Kang, Tae Heung
    Mao, Chih-Ping
    He, Liangmei
    Tsai, Ya-Chea
    Liu, Katherine
    La, Victor
    Wu, T. -C.
    Hung, Chien-Fu
    PLOS ONE, 2012, 7 (04):
  • [35] NKG2D LIGAND EXPRESSION AND TUMOR DORMANCY IN BRAIN METASTASES
    Flueh, C.
    Mafael, V.
    Adamski, V.
    Hattermann, K.
    Synowitz, M.
    Held-Feindt, J.
    NEURO-ONCOLOGY, 2018, 20 : 272 - 272
  • [36] NKG2D function protects the host from tumor initiation
    Smyth, MJ
    Swann, J
    Cretney, E
    Zerafa, N
    Yokoyama, WM
    Hayakawa, Y
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (05) : 583 - 588
  • [37] NKG2D ligands in tumor immunity: two sides of a coin
    Zhang, Jinyu
    Basher, Fahmin
    Wu, Jennifer D.
    FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [38] NKG2D and cytotoxic effector function in tumor immune surveillance
    Hayakawa, Yoshihiro
    Smyth, Mark J.
    SEMINARS IN IMMUNOLOGY, 2006, 18 (03) : 176 - 185
  • [39] Immunomodulating Anti-Tumor Effects With Telomerase-Mediated Telomere Targeted Therapy and Radiotherapy in Glioblastoma
    Huntoon, Kristin
    Kim, Betty Y. S.
    Jiang, Wen
    Shay, Jerry
    NEUROSURGERY, 2025, 71 : 243 - 244
  • [40] Lysine acetylation of NKG2D ligand Rae-1 stabilizes the protein and sensitizes tumor cells to NKG2D immune surveillance
    Hu, Jiemiao
    Xia, Xueqing
    Zhao, Qingnan
    Li, Shulin
    CANCER LETTERS, 2021, 502 : 143 - 153